Does serum butyrylcholinesterase level determine the severity and mortality of COVID-19 pneumonia?: Prospective study

Does serum butyrylcholinesterase level determine the severity and mortality of COVID-19 pneumonia?: Prospective study

BackgroundThe WHO emphasized the importance of knowing the risk factors for the severity of the disease in the COVID-19 pandemic. Our aim in this study was to determine the relationship between serum Butyrylcholinesterase (BChE) level, which is rapidly affected by inflammation, and the severity of C...

Full description

Bibliographic Details
Main Authors: Hilal Sipahioglu, Aliye Esmaoglu, Ayse Kiris, Zehra Bestepe Dursun, Sibel Kuzuguden, Mine Altinkaya Cavus, Cem Artan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Medicine
Subjects:
COVID-19
pneumonia
butyrylcholinesterase
marker
mortality
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.940533/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.940533/full

Similar Items